Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
0.0001
0.0000
(0.00%)
As of March 3 at 3:00:00 PM EST. Market Open.
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 4.15M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| DUBIN THOMAS I.H. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 8, 2024 |
| GRANEY THOMAS Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 8, 2024 |
| FEINBERG PETER Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 8, 2024 |
| PATSI TUOMO Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 8, 2024 |
| BOCK THOMAS A. M.D. Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 8, 2024 |
| GALEN MICHELE Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 8, 2024 |
| FR CAPITAL HOLDINGS, L.P. Beneficial Owner of more than 10% of a Class of Security | Sale at price 1.89 per share. | Indirect | 94,670 | Jan 2, 2024 |
| FR CAPITAL HOLDINGS, L.P. Beneficial Owner of more than 10% of a Class of Security | Sale at price 1.83 - 2.01 per share. | Indirect | 54,136 | Dec 29, 2023 |
| FR CAPITAL HOLDINGS, L.P. Beneficial Owner of more than 10% of a Class of Security | Sale at price 2.08 - 2.16 per share. | Indirect | 66,460 | Dec 27, 2023 |
| FR CAPITAL HOLDINGS, L.P. Beneficial Owner of more than 10% of a Class of Security | Sale at price 2.41 - 2.51 per share. | Indirect | 115,475 | Dec 22, 2023 |
| BACKENROTH SAMUEL Chief Financial Officer | -- | Direct | -- | Mar 31, 2023 |
Related Tickers
ETBI Eastgate Biotech Corp.
0.0045
+4,400.01%
MDCLF MedinCell S.A.
6.98
0.00%
ATHXQ Athersys, Inc.
0.0000
0.00%
HOPHF Hemogenyx Pharmaceuticals Plc
1.2400
0.00%
ELDN Eledon Pharmaceuticals, Inc.
3.9200
-2.12%
DMAC DiaMedica Therapeutics Inc.
5.98
-3.74%
SCPX Scorpius Holdings, Inc.
0.1481
-7.38%
RZLT Rezolute, Inc.
4.0000
-3.38%
PULM Pulmatrix, Inc.
7.03
-9.76%
ATHE Alterity Therapeutics Limited
3.5800
-1.65%